FDA Inspection 1207536 — Parker Laboratories, Inc.

Parker Laboratories, Inc. — FEI 2212018

The FDA completed an inspection of Parker Laboratories, Inc. on May 23, 2023 in Fairfield, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 4 citations were issued during this inspection. Product area: Devices.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
May 23, 2023
Fiscal Year
2023
Product Type
Devices
Project Area
Compliance: Devices
Location
Fairfield, NJ (United States)

Citations

IDCFRDescription
311921 CFR 820.75(b)Lack/Inad procedure-Monitoring/Control of Validated Proces
368621 CFR 820.90(b)(2)Product rework documentation, DHR {see also 820.184}
53921 CFR 820.70(b)Production and Process Change Procedures, lack of or Inad.
54621 CFR 820.75(a)Lack of or inadequate process validation

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.